×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LEXX – lexaria bioscience corp. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LEXX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
09:22 am
lexx
Lexaria's Registered GLP-1 Study #4 Begins Dosing [Yahoo! Finance]
Medium
Report
Lexaria's Registered GLP-1 Study #4 Begins Dosing [Yahoo! Finance]
12/19
09:05 am
lexx
Lexaria's Registered GLP-1 Study #4 Begins Dosing
Medium
Report
Lexaria's Registered GLP-1 Study #4 Begins Dosing
12/18
09:45 am
lexx
Lexaria Forms New Scientific Advisory Board [Yahoo! Finance]
Low
Report
Lexaria Forms New Scientific Advisory Board [Yahoo! Finance]
12/18
09:25 am
lexx
Lexaria Forms New Scientific Advisory Board
Low
Report
Lexaria Forms New Scientific Advisory Board
12/17
09:10 am
lexx
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Medium
Report
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
12/9
09:34 am
lexx
Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5 [Yahoo! Finance]
Medium
Report
Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5 [Yahoo! Finance]
12/9
09:10 am
lexx
Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5
Low
Report
Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5
12/2
08:06 am
lexx
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/18
01:09 pm
lexx
Form 8-K Lexaria Bioscience Corp. For: Dec 16
Neutral
Report
Form 8-K Lexaria Bioscience Corp. For: Dec 16
12/18
06:01 am
lexx
Form EFFECT Lexaria Bioscience Corp.
Low
Report
Form EFFECT Lexaria Bioscience Corp.
12/16
04:06 pm
lexx
Form POS AM Lexaria Bioscience Corp.
Low
Report
Form POS AM Lexaria Bioscience Corp.
12/6
06:02 am
lexx
Form EFFECT Lexaria Bioscience Corp.
Medium
Report
Form EFFECT Lexaria Bioscience Corp.
12/5
04:57 pm
lexx
Form 424B3 Lexaria Bioscience Corp.
Low
Report
Form 424B3 Lexaria Bioscience Corp.
12/3
02:03 pm
lexx
Form 4 Lexaria Bioscience Corp. For: Dec 02 Filed by: CHRISTOPHER RICHARD
Medium
Report
Form 4 Lexaria Bioscience Corp. For: Dec 02 Filed by: CHRISTOPHER RICHARD
11/27
02:39 pm
lexx
Form DEF 14A Lexaria Bioscience Corp. For: Jan 14
Neutral
Report
Form DEF 14A Lexaria Bioscience Corp. For: Jan 14
11/26
04:42 pm
lexx
Form S-3 Lexaria Bioscience Corp.
Low
Report
Form S-3 Lexaria Bioscience Corp.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: